MetaCap

Sera Prognostics Statistics

NASDAQ: SERAHealth CareMedical SpecialitiesUSD

2.07+0.02 (+0.98%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Sera Prognostics by the numbers

Sera Prognostics has a market capitalization of $81.7 million based on 38.48M shares outstanding. With trailing EPS of $-0.67, Sera Prognostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.2% above its 50-day average and 7.7% below its 200-day average.

Average daily trading volume is 28.38K shares, or about $58,755 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SERA valuation vs. peer median

SERA compared with the median of 8 peer companies
MetricSERAPeer medianDifference
Market cap$81.66M$23.31M+250%
Avg. volume28.38K40.70K-30%

Peer median across 8 companies: KEQU, MDXH, ACH, ADVB, AMS, ACON, BGLC, BNR.

Valuation

Price and trading

Previous close
2.05
Open
2.01
Day range
2.01 – 2.07
52-week range
1.56 – 3.95
52-week change
-36.31%
Beta
—

Dividends and events

Annual dividend
None
Next earnings date
Aug 12, 2026

Additional statistics

Market Cap
81.66M
Forward Pe
-3.87
Eps
-0.67
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
3.95
Week52 Low
1.56
Avg Volume
28,384.00
Shares Outstanding
38.48M
Ma50
2.04
Ma200
2.24
Earnings Date
Aug 12, 2026
Pct From52w High
-47.59%
Pct From52w Low
32.69%

Related